Top news of the week: 24.08.2023.
11 Most Undervalued Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most undervalued biotech stocks to buy according to analysts. To skip our analysis of the recent trends, and market activity, you can go ...
Concord Biotech to list on Friday. Here’s what GMP suggests
Analysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which comprises many niche biopharma products
2 Biotech Stocks That Could Make You Richer
Neither is performing particularly well this year compared to the broader market, but don't let that chase you away.
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Are More Bearish Than They Used To Be
Today is shaping up negative for POINT Biopharma Global Inc. ( NASDAQ:PNT ) shareholders, with the analysts delivering...
3 Green Flags for Biotech Stocks in 2023 and Beyond
The industry is changing rapidly, and for the better.
US a key market, have strong presence in it: Ankur Vaid, Concord Biotech
So we expect to do better than what we have done historically, which was a CAGR growth of 18%. And this as economies of scale would kick in once a new site starts ramping up, we see our ...
Stocks in news: Nykaa, HDFC AMC, Concord Biotech, JSW Steel, Adani Energy
Nykaa, HDFC AMC, Indus Towers, Page Industries and ACC have been excluded from Nifty Next50 in the latest revision of various NSE indices.
This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher
"I think it's going to be worth more," Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment.